| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0001 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -7.3e-05 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 6.6e-05 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -4.2e-05 | 1 |